Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Razak Pharmaceutical Company is a prominent Iranian pharmaceutical manufacturer with a history dating back to 1964, when it was established as a subsidiary of Pfizer. Following its nationalization, the company evolved into a major player in the Middle Eastern healthcare sector, producing an extensive portfolio of human and veterinary medicines. Its product range includes essential generics across therapeutic areas such as cardiology, gastroenterology, and infectious diseases, as well as specialized animal health products. The company is publicly listed on the Tehran Stock Exchange and operates under the Tamin Pharmaceutical Investment Company (TPICO) umbrella. Razak maintains high-standard manufacturing facilities that comply with international GMP guidelines to serve both domestic and export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Razak Pharmaceutical Company.